4

FORM 4 - SB 12.12.25

Company: Eton Pharmaceuticals, Inc.
Filed: December 12, 2025
Period of Report: December 12, 2025
Accession Number: 0001437749-25-037741

View Document ↗ View on SEC.gov ↗